Introducing the Novaerus Defend 1050
All-in-One Air Disinfection and Purification Device
DUBLIN, Ireland, June 28, 2018 — Novaerus, an Irish company specializing in non-chemical air disinfection using patented NanoStrike technology, today announced the launch of the Defend 1050. The Defend 1050 is a portable, medical-grade device designed for rapid air disinfection and purification in large spaces and high-risk environments, including operating theatres, ICUs, IVF labs, emergency rooms, waiting areas, and construction zones.
The Defend 1050 combines NanoStrike™ Technology with multi-stage filtration to safely disinfect indoor air, supplementing surface cleaning and hand hygiene for comprehensive infection control.
FDA Clearance Update: The FDA cleared the Defend 1050 (NV 1050) as a 510(k) Class II Medical Device.
Rapid Pathogen Destruction & Multi-Stage Filtration
The Defend 1050 uses NanoStrike plasma technology—a rapid pathogen destruction method—alongside a multi-stage high-performance filter system from Camfil®. The unit combines six coils of patented NanoStrike technology with an M5 pre-filter, a certified H13 HEPA filter (EN-1822 standard), and a carbon/molecular filter to neutralize volatile organic compounds (VOCs), eliminate odors, and trap particulate down to 0.3 µm.
Independent Efficacy & Test Results
Independent laboratory testing demonstrates that the Defend 1050 operates with high efficacy at maximum speed:
| Target Pathogen / Pollutant | Reduction % | Timeframe | Test Space Volume |
|---|---|---|---|
| Mycobacterium smegmatis (TB surrogate) | 97.00% | 30 min | 30 m³ |
| Influenza A | 99.90% | 10–20 min | 28.5 m³ |
| Staphylococcus epidermidis | 99.90% | 15 min | 30 m³ |
| Aspergillus niger (Fungal spores) | 99.99% | 30 min | 15.9 m³ |
| Nitrogen Dioxide (NO₂) | 100.00% | 6 min | 16 m³ |
| Formaldehyde | 99.68% | 1.1 min | 16 m³ |
| Toluene (VOC) | 99.00% | 9.1 min | 19.72 m³ |
| PM 1.0 & PM 2.5 | CADR ~870 m³/hr | Continuous | 19.7 m³ |
Explore all peer-reviewed research and independent test results →
Executive Commentary
“We created the Defend 1050 in response to a growing demand from our customers for a mobile, rapid remediation solution for airborne pathogens and VOCs in high-risk situations. As a problem solver, the Defend 1050 is the perfect complement to our filter-free units—the Protect 900, Protect 800, and Protect 200—which are designed to operate continuously to maintain optimal indoor air quality.”
— Dr. Kevin Devlin, CEO at Novaerus
“We now know conclusively that infection can be transmitted on air currents over large distances, by direct and indirect contact, or a combination of all three routes. The Defend 1050 is ideal for mitigating the risk of airborne dissemination of infection and contamination of surfaces and hands by reducing the bioburden in the air.”
— Dr. Felipe Soberon, Chief Technology Officer at Novaerus
“Novaerus has done an incredible job of bringing together the benefits of their patented NanoStrike technology and our high-performance filters. As an emerging global leader in portable non-chemical air disinfection, Novaerus is a natural partner for us. By being embedded in Novaerus units, Camfil’s filters can be deployed at the point of care, when and where they are needed most.”
— Paul Flanagan, General Manager of Camfil Ireland
Inactivation Before Filtration
Many traditional air-cleaning methods in healthcare rely solely on filters to capture pathogens. Without deactivating pathogens first, standard filters can become breeding grounds where viable microorganisms colonize. Novaerus NanoStrike technology solves this issue by inactivating airborne pathogens before they ever reach the filter media.
The Defend 1050 features wheels for easy mobility between rooms, plugs into standard electrical outlets, and offers five adjustable fan speeds for varied room sizes and acoustic requirements. Watch how the Defend 1050 system works in real time.
Company Information
About Novaerus
Novaerus is on a mission to reduce indoor airborne pollutants that lead to infection, allergies, asthma, and irritation. The patented plasma technology used in Novaerus portable devices was invented in Ireland in 2006, with clinical testing starting in 2008. In 2016, Novaerus acquired Plasma Air, expanding into HVAC bipolar ionization and industrial applications. Learn more about our company story.
About Camfil
For over 50 years, Camfil has been a world leader in premium clean air solutions, producing commercial and industrial systems for air filtration and air pollution control. Headquartered in Stockholm, Sweden, Camfil operates 28 manufacturing sites, six R&D centers, and local sales offices across 26 countries. To learn more, visit www.camfil.com.